Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 22,500 shares, a growth of 5,525.0% from the December 31st total of 400 shares. Based on an average trading volume of 85,500 shares, the days-to-cover ratio is currently 0.3 days.
Analyst Ratings Changes
LZAGY has been the topic of a number of research reports. Redburn Atlantic raised shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, November 27th. The Goldman Sachs Group raised Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th.
Check Out Our Latest Research Report on Lonza Group
Lonza Group Price Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Articles
- Five stocks we like better than Lonza Group
- What is the NASDAQ Stock Exchange?
- Oklo’s Fuel Partnership Strengthens Bullish Case for Stock
- Investing in Construction Stocks
- SLB: Pioneering the Shift from Oil Services to Tech Solutions
- With Risk Tolerance, One Size Does Not Fit All
- Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.